Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALAB vs MRNA✓SelectedUSD · MRNAALAB vs MRNA performance historyLatest closeAs of+4.58%11/17
Stock and ETF performance explorer

ALAB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+241.1%
MRNA return
+100.0%
Excess return
+141.1%
Maximum drawdown
-63.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+4.6%-3.9%+8.5%+4.8%
7D-2.1%-17.6%+15.4%-1.1%
30D-26.0%-5.1%-20.8%-25.6%
3M-33.9%+220.8%-254.7%-39.3%
6M-9.1%+321.7%-330.8%-22.6%
YTD+27.2%+601.3%-574.1%-6.2%
1Y+49.7%+735.2%-685.6%+5.9%
All+241.1%+100.0%+141.1%+196.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling